ITGAL and invasive breast carcinoma: According to the TIMER database, we discovered that ITGAL expression levels are increased in breast invasive carcinoma, kidney renal clear cell carcinoma, kidney renal papillary cell carcinoma, and stomach adenocarcinoma (STAD), but are decreased in colon adenocarcinoma and lung adenocarcinoma compared with peritumor tissues.